Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Vaxxinity Inc. currently has 1 pending office action within its company patent portfolio. This single matter is assigned to 1 distinct examiner. The data indicates that there are 0 distinct art units associated with this pending action, which simplifies the administrative tracking of the case.
CHANG YU WANG is identified as the busiest examiner for the portfolio, as he is responsible for the 1 pending office action. Since there is only 1 distinct examiner involved, Wang's specific approach to examination will be the primary factor in the outcome of this matter. The absence of multiple examiners or art units creates a highly centralized prosecution environment.
Practitioners should focus their strategy on the 1 pending action under Wang's review. With 1 distinct examiner and 0 distinct art units, the prosecution process is streamlined. This allows for a direct and focused engagement with the examiner to address the requirements of the 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WANG, CHANG YU | 1 | 33.5% | +53.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18688196 | METHODS FOR THE PREVENTION AND TREATMENT OF SYNUCLEINOPATHIES | WANG, CHANG YU | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18688196 | METHODS FOR THE PREVENTION AND TREATMENT OF SYNUCLEINOPATHIES | WANG, CHANG YU | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18688196 | METHODS FOR THE PREVENTION AND TREATMENT OF SYNUCLEINOPATHIES | WANG, CHANG YU | — | §102§103§112 | Non-Final OA | — | Pending | Feb 29, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial